DOCGO INC (DCGO) Fundamental Analysis & Valuation

NASDAQ:DCGO • US2560861096

Current stock price

0.5198 USD
-0.06 (-9.88%)
At close:
0.5198 USD
0 (0%)
After Hours:

This DCGO fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. DCGO Profitability Analysis

1.1 Basic Checks

  • In the past year DCGO has reported negative net income.
  • In the past year DCGO had a positive cash flow from operations.
  • Of the past 5 years DCGO 4 years were profitable.
  • The reported operating cash flow has been mixed in the past 5 years: DCGO reported negative operating cash flow in multiple years.
DCGO Yearly Net Income VS EBIT VS OCF VS FCFDCGO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 50M -50M -100M -150M

1.2 Ratios

  • The Return On Assets of DCGO (-84.02%) is worse than 91.00% of its industry peers.
  • Looking at the Return On Equity, with a value of -126.66%, DCGO is doing worse than 75.00% of the companies in the same industry.
Industry RankSector Rank
ROA -84.02%
ROE -126.66%
ROIC N/A
ROA(3y)-26.08%
ROA(5y)-12.36%
ROE(3y)-39.38%
ROE(5y)-18.94%
ROIC(3y)N/A
ROIC(5y)N/A
DCGO Yearly ROA, ROE, ROICDCGO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 -20 -40 -60 -80 -100

1.3 Margins

  • Looking at the Gross Margin, with a value of 30.65%, DCGO is in line with its industry, outperforming 60.00% of the companies in the same industry.
  • DCGO's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for DCGO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 30.65%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.43%
GM growth 5Y-1.62%
DCGO Yearly Profit, Operating, Gross MarginsDCGO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. DCGO Health Analysis

2.1 Basic Checks

  • DCGO does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • DCGO has less shares outstanding than it did 1 year ago.
  • DCGO has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, DCGO has an improved debt to assets ratio.
DCGO Yearly Shares OutstandingDCGO Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
DCGO Yearly Total Debt VS Total AssetsDCGO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

2.2 Solvency

  • Based on the Altman-Z score of -0.12, we must say that DCGO is in the distress zone and has some risk of bankruptcy.
  • DCGO has a worse Altman-Z score (-0.12) than 78.00% of its industry peers.
  • DCGO has a debt to FCF ratio of 0.63. This is a very positive value and a sign of high solvency as it would only need 0.63 years to pay back of all of its debts.
  • DCGO's Debt to FCF ratio of 0.63 is amongst the best of the industry. DCGO outperforms 88.00% of its industry peers.
  • A Debt/Equity ratio of 0.08 indicates that DCGO is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.08, DCGO is in the better half of the industry, outperforming 77.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 0.63
Altman-Z -0.12
ROIC/WACCN/A
WACC8.34%
DCGO Yearly LT Debt VS Equity VS FCFDCGO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

2.3 Liquidity

  • DCGO has a Current Ratio of 2.26. This indicates that DCGO is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Current ratio value of 2.26, DCGO belongs to the best of the industry, outperforming 82.00% of the companies in the same industry.
  • DCGO has a Quick Ratio of 2.26. This indicates that DCGO is financially healthy and has no problem in meeting its short term obligations.
  • DCGO's Quick ratio of 2.26 is amongst the best of the industry. DCGO outperforms 82.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.26
Quick Ratio 2.26
DCGO Yearly Current Assets VS Current LiabilitesDCGO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. DCGO Growth Analysis

3.1 Past

  • DCGO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -747.31%.
  • Looking at the last year, DCGO shows a very negative growth in Revenue. The Revenue has decreased by -47.74% in the last year.
  • Measured over the past years, DCGO shows a very strong growth in Revenue. The Revenue has been growing by 27.91% on average per year.
EPS 1Y (TTM)-747.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3525%
Revenue 1Y (TTM)-47.74%
Revenue growth 3Y-9.9%
Revenue growth 5Y27.91%
Sales Q2Q%-37.98%

3.2 Future

  • The Earnings Per Share is expected to grow by 36.68% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 0.44% on average over the next years.
EPS Next Y79.29%
EPS Next 2Y36.68%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-6.07%
Revenue Next 2Y0.44%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
DCGO Yearly Revenue VS EstimatesDCGO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
DCGO Yearly EPS VS EstimatesDCGO Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 -0.5 -1 -1.5

More info and screens

Find the best growth stocksShow best growing peers

2

4. DCGO Valuation Analysis

4.1 Price/Earnings Ratio

  • DCGO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DCGO. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DCGO Price Earnings VS Forward Price EarningsDCGO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

  • 100.00% of the companies in the same industry are more expensive than DCGO, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 1.88
EV/EBITDA N/A
DCGO Per share dataDCGO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3

4.3 Compensation for Growth

  • DCGO's earnings are expected to grow with 36.68% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y36.68%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. DCGO Dividend Analysis

5.1 Amount

  • DCGO does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

DCGO Fundamentals: All Metrics, Ratios and Statistics

DOCGO INC

NASDAQ:DCGO (4/10/2026, 8:16:19 PM)

After market: 0.5198 0 (0%)

0.5198

-0.06 (-9.88%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)03-16
Earnings (Next)05-06
Inst Owners43.18%
Inst Owner Change0%
Ins Owners3.99%
Ins Owner Change13.98%
Market Cap50.84M
Revenue(TTM)322.20M
Net Income(TTM)-182.40M
Analysts78.33
Price Target2.24 (330.93%)
Short Float %6.33%
Short Ratio6.19
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-457.91%
Min EPS beat(2)-920.08%
Max EPS beat(2)4.26%
EPS beat(4)1
Avg EPS beat(4)-310.48%
Min EPS beat(4)-920.08%
Max EPS beat(4)4.26%
EPS beat(8)3
Avg EPS beat(8)-156.05%
EPS beat(12)3
Avg EPS beat(12)-141.78%
EPS beat(16)6
Avg EPS beat(16)-88.85%
Revenue beat(2)1
Avg Revenue beat(2)1.96%
Min Revenue beat(2)-0.5%
Max Revenue beat(2)4.42%
Revenue beat(4)2
Avg Revenue beat(4)-1.03%
Min Revenue beat(4)-9.68%
Max Revenue beat(4)4.42%
Revenue beat(8)3
Avg Revenue beat(8)-1.79%
Revenue beat(12)6
Avg Revenue beat(12)1.01%
Revenue beat(16)10
Avg Revenue beat(16)2.52%
PT rev (1m)-12%
PT rev (3m)-20%
EPS NQ rev (1m)-4.16%
EPS NQ rev (3m)-12.06%
EPS NY rev (1m)0%
EPS NY rev (3m)-13.26%
Revenue NQ rev (1m)3.22%
Revenue NQ rev (3m)4.68%
Revenue NY rev (1m)2.4%
Revenue NY rev (3m)2.72%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.16
P/FCF 1.88
P/OCF 1.48
P/B 0.35
P/tB 0.35
EV/EBITDA N/A
EPS(TTM)-1.68
EYN/A
EPS(NY)-0.35
Fwd EYN/A
FCF(TTM)0.28
FCFY53.14%
OCF(TTM)0.35
OCFY67.76%
SpS3.29
BVpS1.47
TBVpS1.47
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -84.02%
ROE -126.66%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 30.65%
FCFM 8.39%
ROA(3y)-26.08%
ROA(5y)-12.36%
ROE(3y)-39.38%
ROE(5y)-18.94%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.43%
GM growth 5Y-1.62%
F-Score4
Asset Turnover1.48
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 0.63
Debt/EBITDA N/A
Cap/Depr 47.47%
Cap/Sales 2.31%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.26
Quick Ratio 2.26
Altman-Z -0.12
F-Score4
WACC8.34%
ROIC/WACCN/A
Cap/Depr(3y)48.61%
Cap/Depr(5y)58.54%
Cap/Sales(3y)1.63%
Cap/Sales(5y)1.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-747.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3525%
EPS Next Y79.29%
EPS Next 2Y36.68%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-47.74%
Revenue growth 3Y-9.9%
Revenue growth 5Y27.91%
Sales Q2Q%-37.98%
Revenue Next Year-6.07%
Revenue Next 2Y0.44%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-370.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year76.96%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-58.11%
FCF growth 3Y4.95%
FCF growth 5YN/A
OCF growth 1Y-51.02%
OCF growth 3Y6.07%
OCF growth 5YN/A

DOCGO INC / DCGO Fundamental Analysis FAQ

What is the fundamental rating for DCGO stock?

ChartMill assigns a fundamental rating of 3 / 10 to DCGO.


What is the valuation status for DCGO stock?

ChartMill assigns a valuation rating of 2 / 10 to DOCGO INC (DCGO). This can be considered as Overvalued.


Can you provide the profitability details for DOCGO INC?

DOCGO INC (DCGO) has a profitability rating of 1 / 10.


Can you provide the financial health for DCGO stock?

The financial health rating of DOCGO INC (DCGO) is 7 / 10.


What is the earnings growth outlook for DOCGO INC?

The Earnings per Share (EPS) of DOCGO INC (DCGO) is expected to grow by 79.29% in the next year.